HHS

manualCAD

HHS: we recommend S3. DEA: neat, thanks for the report. (Puts it in the trash) This is where we are right now in the process.

Gambit2112

well i must say. the last year has been an absolute rollercoaster … both presidential candidates mentioning the plant and how it needs reform.. to trump and republicans winning the election , created a strong bear case… trump then wanting matt gaetz as his AG , robert kennedy as head of HHS . trump reiterating the plant shouldn’t. be criminal , now to this hemp ban… meanwhile a lot of the companies in the sector are starting to turn into decent scenarios..:: i’m scared , im excited and in seconds it can pop…..that’s how i felt when i lost my virginity and 22 years later i feel it again

Unaphotobomber

I totally agree, but I will say, as time has proven again and again (biden HHS request, trump random comments) it’s hard to know when news will come.

Many_Easy

The Dems started the HHS review, pushed for SAFE that was blocked by McConnell & not enough GOP votes. Tired of hearing that Biden did nothing. It’s simply untrue.

ivigilanteblog

No need to direct HHS. They are already on board! Need to direct the AG, who can step in and finish the job. Our hopes lie on Pam Bondi's desk...God help us.

skyplt29

DJT To Do List: 1. Sign Executive Order directing DOJ to release Epstein files; 2. Sign Executive Order directing HHS to reschedule cannabis to S3. Too much to ask?

Own_Fold_5212

2026 resolution - stop googling “marijuana rescheduling” every day to see if updates 😂😭 Seems like just yesterday that HHS report in full was released (thank you again Matt Zorn for that gift). 🎁

infamous_merkin

He’s destroying the dollar, screwing up FAA, Whitehouse looks wrecked, courts are tampered with, HHS discredited, climate data deleted, massive unemployment, SNAP benefits cancelled, war is coming.

Many_Easy

Why do you think that **”everything points to S3 under Trump”**? Also, assuming he actually does anything with Schedule 3, do you think it will be finalizing S3 or canceling S3? The longer we move past what he said on August 11th, the more doubtful I become that a positive S3 decision will be made. Remember, most of us were literally believing that HHS recommendation over a year ago would just be a rubber stamp approval by the DEA due to law. Apparently, we were incorrect.

SpongEWorTHiebOb

Same here, when I saw mine I bolted from my computer, much like the HHS secretary.

Relax_Dude_

secretary of HHS quickly flees, just lol

artgarfunkadelic

We live in a world where Dr. Oz would be a more qualified head of HHS.

Austin_Destroyer

RFK was afraid the fainting was contagious. Should you ever see someone faint, you should also run away. He is after all our HHS Secretary and we should follow his example. Now, who wants some heroin?

Retarded_Flu

Palantir is bordering on being irreplaceable. Current government initiatives lean toward centralization, rapid deployment, and data exploitation- Palantir’s exact strength. Gotham is already embedded in DHS, ICE, HHS, and DoD. Rip it out, and the system stalls (i.e. vendor lock-in). Combining these agencies will give Palantir even greater leverage, so keep that in mind.

Gigawatts

“Consult your physician before taking it if you absolutely need to” How is that any different compared to how pregnant women were taking it before? You think pregnant women were taking Tylenol flippantly? What evidence warranted the POTUS and Secretary of HHS hyping up a “historic announcement” about autism leading up to this?

fruitloop00001

Not zero data - https://hsph.harvard.edu/news/using-acetaminophen-during-pregnancy-may-increase-childrens-autism-and-adhd-risk/ This study shows a tentative connection. Certainly nothing that should be receiving this amount of attention from the HHS secretary and President.

hambone_83

>You said Biden's plan was to use it for the election. But then it was not used for the election. I don't understand this. But it was, Harris ran on a platform to continue the process to get it rescheduled and then even went a step further saying she would fully legalize it when it looked like she was going to lose. >Either Biden didn't actually have that power (and thus blame lies with the DEA) or he did have that power and just chose to not execute the plan you are saying he put into motion. This just does not make logical sense. HHS and the science was in favor of rescheduling. The comment period was overwhelmingly in favor of rescheduling. Then DEA sabotages it when the process had evidence it should be done. A DEA that Biden's administration is in charge of. I could understand if HHS doesn't recommend and the comment period was bad that the DEA drags their feet or whatever. But in a process that was looking good they purposefully got in the way. Biden doesn't have to step in and control the outcome but he sure as shit should have controlled that the DEA was unbiased and treated it fairly. Adding unnecessary steps, limiting advocacy witnesses, allowing SAM to put language in what goes onto the record. Biden definitely has power over the conduct of his agencies. >It's your opinion what you think was going on internally in Biden's administration. You are expressing an opinion on where the blame should belong. >When you express a political position in a public forum, you can expect others to chime in with their own opinion. Go ahead I'm not stopping you. Just pointing out that Biden has fault in the process not being finalized (either good or badend result) under his watch. Whether it was used for votes is right or wrong does not matter, what matters is it wasn't done and he and his administration have contributed to that.

Plastic-Meet7490

The original comment was concerned about RFK’s credentials, not whether what he said about autism being speculative (which I agree with actually). I’m bipartisan on these issues, but you getting sidetracked on the real issue of the original comment and not being able to defend the former HHS secretary being a lawyer and not a medical professional does in fact prove how dishonest you are being about the situation. 🤷

Plastic-Meet7490

“RFK has no medical background or training” Is it excusable for Xavier just because he was on “your side”. If you truly felt that it was of importance that the HHS secretary be medically certified then you should be just as upset at the previous administration. Don’t cherrypick. Demand better representation.

Plastic-Meet7490

Xavier B. Was the previous HHS Secretary and was an attorney.

kosmokramr

The source doesn't even link Tylenol to autism. [https://journals.lww.com/epidem/abstract/2009/01000/the\_rise\_in\_autism\_and\_the\_role\_of\_age\_at.16.aspx](https://journals.lww.com/epidem/abstract/2009/01000/the_rise_in_autism_and_the_role_of_age_at.16.aspx) RFK has no medical background or training, for the HHS to move forward with guidance like this is \*autistic\*

Inational_Art

💎🙌 [IBRX] — The Next Big Short Squeeze Nobody’s Ready For 🚀 (My Deep Dive) Alright you beautiful degenerates, I think I just stumbled onto something filthy. Been digging deep into [Ticker IBRX], and what I’m seeing looks like the perfect setup for a short squeeze of biblical proportions. 🧠 Quick Thesis: Insanely high short interest north of 74% on a tiny 98M float, recent ANKTIVA FDA wins lighting a fire under retail while shorts choke on near-100% utilization. And with RFK Jr. now HHS boss draining the big pharma swamp, regulatory roadblocks are crumbling—time to stick it to the suits who’ve been burying actual cancer cures for decades. 💰 The Numbers (aka receipts): • Market Cap: $2.40B • Float: 98.33 million shares • Short Interest: 74.70% (still a beast, even after some covering 🔥) • Days to Cover: 8 • Insider Buying: Yes (117M+ shares scooped up in last 12 months, insiders own 66%+) • Catalyst: Q3 Earnings Nov 12 + sBLA submission for BCG-unresponsive NMIBC + CAR-NK data drop in H2, all supercharged by RFK Jr.’s FDA shakeup greenlighting real innovation over cartel BS 🧨 Why This Screams Short Squeeze: • Shorts are trapped — borrow rates at 1.59% but only 2.6M shares available (utilization ~97%, they’re sweating bullets) • Low float means every buy pushes this thing like a trampoline • Volume drying up = pressure cooker about to blow • Options chain looking spicy AF with call OI stacking heavy at $3 strikes (196K+ contracts total, apes piling in) 📈 Chart Ape Section: Looks like it’s coiling tighter than your ex’s budget. Price hugging above SMA20/50 with RSI at 54 ready to rip higher, and relative volume holding steady quiet before the retail storm hits. 🛡️ RFK Jr. & Regulatory Rage: RFK’s in the HHS hot seat, ally to ImmunityBio founder Soon-Shiong, and he’s got three pipeline apps queued at FDA that big pharma’s been cockblocking. This ain’t just stock plays, it’s apes vs. the machine denying cancer patients real shots at survival. Load up and flip the bird to the denialists; Anktiva’s already saving bladders, next up: lymphoma, glioblastoma, and beyond. Make Cancer Healthy Again 🚀 🧩 Bear Case (because I’m not totally braindead): • Market could nuke everything • Company might dilute (but hey, they just raised clean cash) • Or we could all just be early (and early = wrong in WSB time) 🚨 My Play: • Current Price: Current Price: $2.44 • My Position: 8375k shares • Target: $5 short-term / $10 long-term • Thesis: Shorts have overplayed their hand. All it takes is one spark like RFK fast-tracking that sBLA and this goes full $GME 2.0 mode, curing cancer and crushing hedgies in one glorious moonshot.

Draphippo

Sure. You have synthetic unregulated hemp pretending to be Marijuana throughout the entire nation, in states where marijuana is illegal. This unregulated/Wild West structure is causing harm to consumers. Dangerous pesticides, mold, toxic metals are hospitalizing people. People under age don’t get ID’d at smoke shops buying it. Cartels are using this loop hole to launder money, acquire land and make 100’s of millions of dollars on American soil. Prohibitionists have lost - 40 states have medical use, 25 have recreational, growing year by year. The genie cannot go back into the bottle. Cannabis polls 70+ % for full legalization. The states that have legalized are bringing in billions in tax revenue which is going towards infrastructure and helpful programs for citizens. None of these states will allow this revenue to go away. Medicinally, Cannabis has become a clear winner for a variety of different patient needs. It’s allowing opioid users a safer alternative to pain management. (Opioid use is currently a crisis in America). Lobbying efforts have increased dramatically and you’re now seeing Alcohol and Tobacco companies (which have massive political influence) put up large money for Cannabis lobbying while rolling out their own Cannabis products. Cannabis being Federally Schedule 1 next to heroine, while almost every state has legalized, while having a hemp loophole distributing harmful product across the entire nation..is absurd. This cannot continue. There will be a breaking point. The HHS has recognized that Cannabis doesn’t belong as Schedule 1 with a 220 page report supporting medical efficacy and a recommendation for Schedule 3. The DEA has NEVER in history gone against an HHS recommendation to reschedule. They will legitimize the industry to create a safe product for consumers, to bring in billions of tax revenue, to create economic growth, to provide alternative medicine to patients in need. Trump is for States rights, he’s supported rescheduling and recreational use in Florida, and recently put out a video promoting Cannabis for medical use. It’s only a matter of time, and to think otherwise is irrefutably illogical.

johndsmits

The question leaders should be asking is: *if it does happen, how do we handle it?* I mean the tools, and world order is different from 1929, and we learned a lot from 1929--there should be accident prevention (fed) and accident response (Congress). 2021-covid showed how we learned from the 1919 pandemic (HHS, cares act and ppp), though created some new issues (inflation) Though current leadership wants to go back to 1950/1850. We saw that during covid ("bleach"?), hence good chance history may repeat itself.

AdministrativeWar647

It’s already gone through HHS review and the DEA is in the rulemaking phase. It wouldn’t even require an executive order since it’s an administrative process under the Controlled Substances Act. Important to note though; ONLY changing the scheduling to Schedule III does not change whether it’s legal to sell or possess large amounts of marijuana without a DEA license. Schedule III status means it can be prescribed if approved by the FDA (same as codeine or ketamine for medicinal use) and this would not violate federal law. Currently states that marijuana is legal in, technically it’s still illegal, the states and the fed are just not enforcing the laws on the books. Recreational use, possession, or sale outside the medicinal or research framework implied by changing the schedule of the drug would still violate federal law unless they change that specifically. Also the vast majority of Americans support this… just a bunch of these old ass politicians are too scared to publicly support it so they keep kicking the can down the road. There’s been studies on how much the healthcare system could save by using marijuana, so there are logical reasons for it to happen beyond just public support.

Gambit2112

ugh who knows anymore.. 2 years ago i had my out on CGC after HHS recommendation. held thinking things would get announced… i held now i’m red again… 2 weeks ago held out on TLRY was very much green.. thinkingi it would keep going … now im back red again

UsedState7381

I wonder if things were looking any better here between the years of 2022 and 2023 before the HHS letter recommending rescheduling, price action looked much better than nowadays.

AverageNo130

S3 would appeal to a segment of voters that would be turned off by anything less. imo. BTW, HHS as approved S3 for cannabis. I'll side with that decision.

UsedState7381

I have almost completed my 2 personal targets with investing in MSOS this year: Double my shares count and hit a X amount of money invested, now there's only about $350 left for me to reach my target, and I'm not in a hurry to complete this now. It took me two years to build up this core position, starting from HHS leak in 2023...I am a little proud of this achievement but I also feel like I took advantage of this year's slump too much and have bought more than enough, so after this one last buy, I'll go back to buying other sectors and VT. If rescheduling doesn't even get an announcement this year, then I believe that MSOS will be revisiting low $3s by late December, for the tax loss harvesting. For me it doesn't matter, I bought into a industry at historic lows, value has been destroyed before I got here and the only way to go from here is up(hopefully)...Otherwise I'll just have to hold MSOS back to low $2s again 🤷

Chezzymann

He tried to steal the 2020 election due to lies of election fraud and attempted to install fake electors and when that didn't work, incited a riot on the capitol. This year he pardoned the goons who attempted to overthrow the government. Now he's threatening people who investigated these crimes and using the DOJ as his personal law firm. And now he has a plan to "restore" election integrity and is also using government institutions as his partisan propaganda arm, violating the hatch act.  He has dramatically extended presidential power by transforming many government agencies that historically were relatively independent into direct extensions of his power, firing thousands of employees who didn't comply. That is not normal.  Even people who were reporting economic information he didn't like were removed, calling into question if we can even trust data from, say the BLS or HHS going forward. Not to mention how he created an imaginary "antifa" terrorist organization, which doesn't exist and is decentralized, and is now using that imaginary label as an excuse to intimidate and suppress anyone who is against him, using tools such as the national guard or illegal withholding federal funding to democratic cities to do so.  I'm not saying he's a full dictator yet, but he is checking off all the boxes of someone who has a plan to be one before he is supposed to leave in 2028 (supposed to, he has a lot of Trump 2028 merch being sold...)

AegonTheMeh

Day 1 layoffs: Commerce: 315 employees - Education: 466 employees - Energy: 187 employees - HHS: 1100-1200 employees - HUD: 442 employees - DHS: 176 employees - Treasury: 1446 employees > A senior admin official tells me the numbers in this are not the totality of the RIFs. It’s a “snapshot in time” and represents where things stood at the time of the court filing. Total RIFs will be much larger than the numbers in this filing: https://x.com/shelbytalcott/status/1976778525396156755?s=46

AegonTheMeh

From Politco: The Trump admin, in a court filing, says 7 agencies began RIFs today - Commerce: 315 employees - Education: 466 employees - Energy: 187 employees - HHS: 1100-1200 employees - HUD: 442 employees - DHS: 176 employees - Treasury: 1446 employees

BobWileey

Their last EC had a pretty grim outlook and with the HHS drama that grim outlook was likely an underestimate. This is definitely a gamble, and the options writers are the house that always wins.

goalpost21

Agreed. IMO, S3 will be tied into a broader crackdown on the criminal aspect of illegal substances and cartels. In the nineties Trump stated “you have to legalize drugs to win the drug war”. S3 is the first step. This is why I don’t think it will be announced via tweet or truth social post. I think it will be a press conference with DEA,DOJ and HHS outlining a plan for legality and law efforts to control Illegal drugs.

unkindRyzen

Before the Tylenol fiasco KVUE had a substantially higher call to put ratio. KVUE was actively seeking to divest part or all of the company, stating as much publicly. Activist investors were pushing for this move. I built a position around this and unfortunately the WSJ Tylenol HHS autism article blew it up.

Gambit2112

lol it’s so painful to see stocks i was looking at 2 years ago taking off thousands of percent , but here i thought cannabis would take off with HHS recommendations . now im negative instead of rich… let’s hope this takes off soon

Many_Easy

All very valid points. Also valid that we got through HHS recommendation. At least that was a start and an accomplishment. I keep mentioning opposition by Youngkin and DeSantis. It’s 2025 and we need to focus on what’s going to be done (or not done) with current leaders and current times. Biden is done. Milgram is done. We got Trulieve pushing for A3 again in Florida. Let’s try to focus on that.

Incognew01

NIH Backing, CPT Momentum, and FDA Fast-Track Potential Are Converging **Bionano Genomics Inc.,** isn’t just knocking on the door anymore, **it’s inside the room**. With NIH now actively using Optical Genome Mapping (OGM) in high-impact research like autism, and Centers for Medicare & Medicaid Services (CMS posting a preliminary decision to reimburse **OGM** under a new Category I CPT code, the platform has officially **crossed from outsider tech to institutional infrastructure**. This isn’t hype, it’s validation.  **NIH doesn’t invite just anyone into its fold**. Their use of **OGM** signals that the science is not only revolutionary, but **essential**. When you combine that with CMS’s reimbursement momentum and a political climate where HHS is being pushed to streamline diagnostics, you get a perfect storm of credibility, urgency, and regulatory opportunity.  **FDA approval**? It’s not here yet, but it’s no longer a long shot. The formalities still need to happen, but the **groundwork is being laid in real time**. OGM is already used in Clinical laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA), operating Laboratory Developed Test (LDT), and if NIH’s autism studies deliver the kind of results early adopters expect, FDA clearance could move fast.  **Bionano Genomics made the club**. It’s one of the boys now. And in this game, that means it’s going to be taken seriously, from reimbursement to regulation to clinical adoption. The **science made the case**. The system is catching up.  What’s changing now is **momentum**. The Centers for Medicare & Medicaid Services (CMS) recently posted a preliminary payment determination for a new Category I CPT code covering **OGM** for constitutional genetic disorders. That’s a major signal that the technology is being recognized as clinically useful and reimbursable, two key steps toward broader adoption. Add to that the NIH’s active use of OGM in autism research, and you’ve **got** **institutional validation at the highest level.**

Incognew01

NIH Backing, CPT Momentum, and FDA Fast-Track Potential Are Converging **Bionano Genomics Inc.,** isn’t just knocking on the door anymore, **it’s inside the room**. With NIH now actively using Optical Genome Mapping (OGM) in high-impact research like autism, and Centers for Medicare & Medicaid Services (CMS posting a preliminary decision to reimburse **OGM** under a new Category I CPT code, the platform has officially **crossed from outsider tech to institutional infrastructure**. This isn’t hype, it’s validation.  **NIH doesn’t invite just anyone into its fold**. Their use of **OGM** signals that the science is not only revolutionary, but **essential**. When you combine that with CMS’s reimbursement momentum and a political climate where HHS is being pushed to streamline diagnostics, you get a perfect storm of credibility, urgency, and regulatory opportunity.  **FDA approval**? It’s not here yet, but it’s no longer a long shot. The formalities still need to happen, but the **groundwork is being laid in real time**. OGM is already used in Clinical laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA), operating Laboratory Developed Test (LDT), and if NIH’s autism studies deliver the kind of results early adopters expect, FDA clearance could move fast.  **Bionano Genomics made the club**. It’s one of the boys now. And in this game, that means it’s going to be taken seriously, from reimbursement to regulation to clinical adoption. The **science made the case**. The system is catching up.  What’s changing now is **momentum**. The Centers for Medicare & Medicaid Services (CMS) recently posted a preliminary payment determination for a new Category I CPT code covering **OGM** for constitutional genetic disorders. That’s a major signal that the technology is being recognized as clinically useful and reimbursable, two key steps toward broader adoption. Add to that the NIH’s active use of OGM in autism research, and you’ve **got** **institutional validation at the highest level.**

Incognew01

NIH Backing, CPT Momentum, and FDA Fast-Track Potential Are Converging **Bionano Genomics Inc.,** isn’t just knocking on the door anymore, **it’s inside the room**. With NIH now actively using Optical Genome Mapping (OGM) in high-impact research like autism, and Centers for Medicare & Medicaid Services (CMS posting a preliminary decision to reimburse **OGM** under a new Category I CPT code, the platform has officially **crossed from outsider tech to institutional infrastructure**. This isn’t hype, it’s validation.   **NIH doesn’t invite just anyone into its fold**. Their use of **OGM** signals that the science is not only revolutionary, but **essential**. When you combine that with CMS’s reimbursement momentum and a political climate where HHS is being pushed to streamline diagnostics, you get a perfect storm of credibility, urgency, and regulatory opportunity.  **FDA approval**? It’s not here yet, but it’s no longer a long shot. The formalities still need to happen, but the **groundwork is being laid in real time**. OGM is already used in Clinical laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA), operating Laboratory Developed Test (LDT), and if NIH’s autism studies deliver the kind of results early adopters expect, FDA clearance could move fast.  **Bionano Genomics made the club**. It’s one of the boys now. And in this game, that means it’s going to be taken seriously, from reimbursement to regulation to clinical adoption. The **science made the case**. The system is catching up.  What’s changing now is **momentum**. The Centers for Medicare & Medicaid Services (CMS) recently posted a preliminary payment determination for a new Category I CPT code covering **OGM** for constitutional genetic disorders. That’s a major signal that the technology is being recognized as clinically useful and reimbursable, two key steps toward broader adoption. Add to that the NIH’s active use of OGM in autism research, and you’ve **got** **institutional validation at the highest level.**

demitasse22

I went to the DOGE website a few months ago. It said DOGE actions saved me $995, over the course of my lifetime. So it cost me less than $1K in taxes over my entire life, to fund USAID, public works, climate initiatives, NASA, the FAA, the FTC, the FCC, the IRS, NOAA, HHS, SNAP, WIC, the Smithsonian , and any “woke” initiatives to improve the conditions of Americans and stabilize world order. I’d gladly pay that.

ivigilanteblog

> My current understanding is that you can't reschedule with an executive order Strong disagree. It can be done, because the parties to whom scheduling has been delegated by Congress (HHS and DEA) serve under the President and are subject to executive orders. It's one of the few executive order ideas that has been mentioned by either party in the last ~50 years that is actually legal and impactful. No idea how the shutdown would affect it, though.

MAG7C

There's simply very little information on this particular idea. No one really knows how this is going to work in practice. I'm basing my statement on the **99.999% of what this guy does and says every single day.** That said: I think we've yet to see any company actually "build domestic supply chains" during this administration so that is still a pie in the sky concept. Promoting things that don't exist is a well known grift. His HHS secretary is a well known huckster and liar. He's going to have a lot of say in how this thing shakes out. The way he is leveraging tariffs is illegal and more fitting with organized crime syndicates than anything else. At the very least, and this is not a small thing, he is self-branding this program at the outset. He's putting his own name on a thing that legally should not exist. Keeping in mind there is no such thing as "Obamacare". Even that name was given as a form of derision. The ACA program is run by the US government, not one man who is no longer in office.

SwordfishOk504

HHS news? This was entirely about Trump sharing that CBD video. HHS made their decision more than two years ago.

vsMyself

we only got one day green on the HHS news?

moneyshake10

Thanks for the correction, haven’t thought about it in over a year now and confused the HHS acronym with the DEA(?) in that context

SwordfishOk504

> I recall HHS fumbling on schedule 3 in the last year of Biden’s term Funny thing about recollections. They can be very wrong. HHS *already recommended* rescheduling in August 2023.

SwordfishOk504

> I recall HHS fumbling on schedule 3 in the last year of Biden’s term Funny thing about recollections. They can be very wrong, like you are here. HHS *already recommended* rescheduling in August 2023.

moneyshake10

I didnt catch the trump post, is what he said actionable in any legal sense? I recall HHS fumbling on schedule 3 in the last year of Biden’s term, and know that the process involves a predictable timeline of hearings and such so, am I hearing that the market expects Trump to bypass typical schedule 3 pipelines? Or what is happening to justify volatile moves in MSOS that isn’t just wishful thinking compared to the recent decades of what-ifs

reeferRabit

So true haha. Reminds me of 2017, late 2020/early 2021, and the HHS comments. If there was a graph of my work productivity, it would be the opposite of my brokerage account lol

theduderino38

HHS recommendation from 2023 I believe or maybe when ALJ process got stuck ….

Weary_Ad162

Still salty he’s going to be the one to get it done aren’t ya? 700+ from HHS rec to S3

Successful-Tea-5733

I think there are 2 issues here. 1 - People are simply looking at this as an otherwise successful company that slipped because of a bad headline and is otherwise a solid company. I think as others have mentioned, there were issues with KVUE before the tylenol situation 2 - People are using the politics to try and capitalize (whether you are for or against Trump) thinking that some people will buy it up at lower prices because they dislike Trump and then you can ride that bounce. FWIW, the situation with Tylenol and pregnancy is not new, I have 3 kids, oldest is 17 and when we were pregant we were told not to take any medication unless absoultely neccessary, and tylenol was specified, were told to use ibuprofen instead. That was 18 years ago. Also, the study mentioned, that wasn't started with the President or HHS. That was a Harvard study. For those on the left who 5 years ago said "follow the science" I find it interesting they don't want to follow the science.

Sozebj

Excerpt from WSJ from 9/24/25. RFK Jr. appears to be helping his trial lawyer buddies shakedown Kenvue: So why the sudden alarm, complete with a presidential presser? The Occam’s razor answer is the influence of RFK Jr., who is carrying water for his friends in the plaintiffs bar. A who’s-who of lawsuit shops are pushing the Tylenol-autism link in federal court. The litigants include the Lanier Law Firm, Beasley Allen, Cooper Law Partners, and Keller Postman. Most have been allies of Mr. Kennedy in other mass torts, such as against the weed-killer Roundup and Merck’s HPV vaccine. Their main lawsuit claim is that Tylenol’s marketer, Kenvue Inc., failed to warn users about an autism-acetaminophen link. But a judge overseeing the litigation rejected their claims two years ago, and in damning fashion. The lawyers are hoping the government will breathe new life into them—conveniently timed for their appeal at the Second Circuit Court of Appeals this fall. Lead attorney Ashley Keller told Reuters last week that he planned to alert the appellate court “if HHS follows through and does the right thing.”

tgff333

Who tf is running the HHS gov X acct.... Since when are drug companies supposed to recommend drugs

Okiedokie84

There had been rumors swirling for at least six months that HHS would be issuing this “guidance” as a result of RFK’s Facebook research. Agent Orange himself only opted to support it because RFK feeds into trump’s praise kink.

rebuildingblocks

This is how I ended up investing in MRNA right before the pandemic (failed to sell at the high, but did very well on it)... It was featured heavily in that Bill Gates 3-parter on Netflix, and I found his faith in them very compelling. (Sold out now but plan to get back in as soon as we are out of the current admin and back to actual scientists in HHS.)

DistributionBroad173

I hope president #48 uses executive orders to fire every #47 appointee on day 1 of the term. The head of the HHS is a lunatic.

Dstein99

Yes -100% is fully bankrupt, the risk with any stock is -100%. I didn't mention anything about Tylenol, HHS, or Trump in my comment, or the likelihood that it would go bankrupt, but that's worst-case scenario with any stock. There are countless ways for any company to go bankrupt, some are known, but many more are unknown.

Sozebj

Editorial from the WSJ 9/24/25 Trump, Tylenol and the Plaintiffs Bar We’ll admit we didn’t see this coming: President Trump advising pregnant women against using one of the most ubiquitous over-the-counter medicines in America. That’s what happened Monday when Mr. Trump joined his health advisers in linking acetaminophen, the main ingredient in Tylenol, to autism. What’s going on here has less to do with healthcare than with a campaign by the plaintiffs bar. “Don’t take Tylenol,” Mr. Trump said standing next to Health and Human Services Secretary Robert F. Kennedy Jr. “Fight like hell not to take it.” If a drug company made the unproven claims aired at the White House, the Food and Drug Administration would threaten legal action. Start with what we know about the causes of autism, which is being diagnosed far more frequently. Gene mutations play a role, and some 800 genes have been linked to the disorder. Many parents conceive children at older ages, which can increase mutation risk. The prenatal environment and in utero exposures may contribute, but the truth is the causal evidence is weak and ambiguous. Broader diagnostic criteria and heightened public awareness have also led to more children with less severe symptoms being diagnosed. Rising autism rates are worrisome and deserve more study. The same goes for the connection between acetaminophen and autism. Some studies have found that neuro-developmental diseases including autism are more common in children of women who use acetaminophen more often during pregnancy. But correlation doesn’t prove causation, and even the evidence of the association is mixed. All of this suggests a need for policy caution, which is why the FDA has for many years declined to change the warning label on Tylenol. One reason is because doctors typically advise that pregnant women take acetaminophen as the safest remedy for fever and pain; anti-inflammatory drugs like ibuprofen can endanger a fetus. Fevers and illnesses during pregnancy increase the risk of congenital defects. They’ve also been associated with autism. The FDA acknowledged as much Monday: “There can be risks for untreated fever in pregnancy, both for the mother and fetus” and “there are contrary studies showing no association” between autism and acetaminophen. So why the sudden alarm, complete with a presidential presser? The Occam’s razor answer is the influence of RFK Jr., who is carrying water for his friends in the plaintiffs bar. A who’s-who of lawsuit shops are pushing the Tylenol-autism link in federal court. The litigants include the Lanier Law Firm, Beasley Allen, Cooper Law Partners, and Keller Postman. Most have been allies of Mr. Kennedy in other mass torts, such as against the weed-killer Roundup and Merck’s HPV vaccine. Their main lawsuit claim is that Tylenol’s marketer, Kenvue Inc., failed to warn users about an autism-acetaminophen link. But a judge overseeing the litigation rejected their claims two years ago, and in damning fashion. The lawyers are hoping the government will breathe new life into them—conveniently timed for their appeal at the Second Circuit Court of Appeals this fall. Lead attorney Ashley Keller told Reuters last week that he planned to alert the appellate court “if HHS follows through and does the right thing.” And what do you know, HHS will now promote a “nationwide public service campaign to inform families” about the alleged link. The transparent goal is to drum up more claims to drive a bigger damage award or settlement. The FDA said it will also initiate “a safety label change for acetaminophen” in response “to prior clinical and laboratory studies that suggest a potential association between acetaminophen use during pregnancy and adverse neurodevelopmental outcomes” despite a “ lack of clear causal evidence.” (Our italics.) The lawsuits cite small studies that suffer from a variety of methodological problems and don’t control for confounding variables like maternal illness and genetics, as federal Judge Denise Cote explained in a 148-page ruling in 2023. She eviscerated the analysis of these studies by the plaintiffs’ experts. “Their analyses have not served to enlighten but to obfuscate the weakness of the evidence on which they purport to rely and the contradictions in the research,” she wrote. Their approach “permitted cherry-picking, allowed a results- driven analysis, and obscured the complexities, inconsistencies, and weaknesses in the underlying data.” The best studies have tried to control for maternal genetic risk and fevers during pregnancy by examining a woman’s acetaminophen use and autism among different children. Those studies found no link, but the plaintiffs’ experts ignored them. Their “testimony does not reflect a reliable application of scientific methods,” Judge Cote wrote. Perhaps no one told Mr. Trump about this trial lawyer campaign, but the costs of his intervention aren’t benign. He’s raising public fear about a useful medicine in a way that could harm maternal and fetal health. Whatever happened to do no harm? The acetaminophen link to autism is based on weak evidence pushed by RFK and his legal allies.

Many_Easy

I’m bullish as well for my cannabis stocks and industry. More like cautiously optimistic with S3 decision AND pro-cannabis reforms. Wonder if they’ll follow the science from HHS recommendation, start over, and/or just use “common sense.”

Many_Easy

All I have to mention is that someone put this HHS review in motion to get us to this point. Also, a certain person issued pardons for simple marijuana possession Furthermore, you don’t know what will happen. No one does. Want credibility, talk facts. And yes, timelines if stated do matter.

thedeadcricket

Pharma is not the easiest play when HHS has unqualified leadership. Why hasn't RGK made a push for weed yet? Weed and psychedelics were part of his 2024 campaign.

darodardar_Inc

15 years heroin = HHS leadership material

Full_Boysenberry_198

HHS is just vibes now

Choledocolithotripsy

The heroin addict running HHS says Tylenol causes autism - Wall Street Journal

Cool_Ad_5101

If trump was smart he would reschedule to schedule 5. He should say he felt Biden didn’t go far enough. We want to reschedule to 5 and then monitor before we make any determinations on descheduling. That would not only steal the win but make it his as he isn’t just going with the HHS recommendation 

Many_Easy

Why can’t you stick to discussion at hand? Ad hominem and whataboutism often resorted to when you can’t discuss. S3 wouldn’t even be discussed in terms of “few weeks” unless HHS review started. Welcome discussing with you when you are ready to acknowledge factual information.

ComprehensiveKiwi489

Is the NCIA's proposal on asking to have 280E removed, is completely separate from the HHS / DEA re-scheduling process? Can that be done while weed is on S1?

Excellent-Package285

I seem to recall an epic "I just sold" announcement from someone in here like 2-3 days before the HHS news in 2023

Simplylegalize

Yes. HHS deserves a lot of credit but that was one piece of the puzzle and it doesn’t seem the most important piece because DEA makes final decision. They did come out with a 256 page report supporting the medical use of marijuana in America which is very good for industry in general.

AverageNo130

And the HHS deserves credit for actually doing their job and then approving S3 on Aug '23.

Pleasant-Bake7402

Elevidys still moving, insurers starting to fold. srpt already generating sales, HHS considering DMD screening at birth. We’re early, man.

UsedState7381

The S3 breadcrumbs we got from Sara Carter today we're not exactly what I was hoping for, and I don't see how weedstock folks on Twitter are interpreting that as bullish, it isn't. HHS and the OLC said S3, the science about it is already done and the process has stalled long enough, there is no need for more pondering, either they do it, or not...Stalling at this point is simply inexcusable. In other words, this is carrot-dangling talk, they will hold this shit back until they see when it will the most profitable for them to exploit it. I hate all of this. Here's hoping that we see something good this weekend or otherwise I'll be considering leaving.

SwordfishOk504

Archived here: https://archive.is/2SR2N Some key points: Rescheduling would mean many additional strict rules American cannabis producers will have to adhere to: >If cannabis is moved to Schedule III, the implications are profound. It would acknowledge cannabis’s medical use and lower abuse potential, unlocking relief from IRS 280E tax penalties, improving banking access, and expanding research opportunities. But it would definitely not legalize recreational cannabis nationwide. States would still govern access, DEA oversight would remain, and businesses would face the daunting task of complying with FDA standards and pharmaceutical-level GMP requirements. Rescheduling is a step forward—but not the final destination. >The reality, however, is that rescheduling isn’t something a president can simply declare. The process requires coordinated evaluations from HHS and FDA, followed by DEA rulemaking and a public comment period. Legal challenges are likely, and procedural snags already delayed the Biden-era effort. Trump’s statement that a decision could come “in the next few weeks” is aspirational at best. >The main point here is that rescheduling is not legalization. It’s not even a clear invitation to participate in a normalized federal marketplace. Instead, it’s a reclassification that drags the cannabis sector out of the shadows of total prohibition and into a pharmaceutical-style framework. That means **DEA registration, FDA oversight, and full compliance with Good Manufacturing Practices (GMP)**. For an industry built on entrepreneurial grit, cultural rebellion, and patchwork state rules, the compliance reality is going to feel like a sharp turn in the music.

SmokieTheLord

Biotech feels shaky given the current HHS’s crusade on real science

KAI5ER

# Key points * **Why it matters:** Schedule III acknowledges medical use and lowers abuse classification; symbolism aside, it could unlock capital and legitimacy—but with heavy federal controls. * **Not legalization:** Adult-use remains state-governed. Federal oversight would sit **on top of** state rules, creating a dual-regime many small operators will struggle to navigate. * **Compliance burden:** Expect **DEA licenses**, meticulous inventory controls, **cGMP/QMS**, validated processes, stability data, and disciplined labeling/claims at FDA standards. * **Process reality:** A president can’t “flip a switch.” HHS/FDA evaluation, DEA rulemaking, comments, and probable legal challenges mean timing is uncertain despite political signals. * **Global lessons:** Germany and Canada show **EU-GMP/Pharma-grade** regimes shrink the field and raise costs; Morocco shows legacy producers need capital/partners to survive. * **State–federal friction:** Conflicting standards (packaging, claims, distribution) will create **operational gray zones** until clear federal guidance arrives. * **Economics:** Compliance costs (facilities, staff, audits, systems) are **millions**—driving **M&A**, PE involvement, and potential pharma entry. # Author’s thesis Rescheduling is the **overture** to a pharma-style framework. Success hinges on operators embracing compliance as the price of legitimacy; resistance risks being left behind.

AverageNo130

I'll go with the HHS S3 approval.

growgain

Happens everytime I go on holidays. HHS news i was in Mexico. Last Trump news dropped when I was on holidays too. Unfortunately my next holiday isn't until mid November.

psellers237

There are literally dozens of studies on this. And you literally chose to bring up Florida specifically. So yeah. You chose it. Since I’m just being ideological, how about we try another study measuring the exact same thing, but by region, and not by two very specific states? https://www.cdc.gov/mmwr/volumes/72/wr/mm7218a4.htm > The COVID-19–associated age-adjusted death rate was lowest (49.5 per 100,000) in HHS Region 1 (Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont) and highest (69.3) in Region 6 (Arkansas, Louisiana, New Mexico, Oklahoma, and Texas). The second highest age-adjusted COVID-19 death rate (65.5) and highest number of COVID-19–associated deaths (56,695) occurred in Region 4 (Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee). Weird. Does the CDC count?

ShadowLiberal

He got the vaccine, but unlike other politicians such as Biden he didn't make a PR event of it by getting it on camera to show his own supporters that it was safe. And he chose a guy who's very clearly anti-vaccine to run the HHS.

TodashBurner

You bought Moderna calls, with anti vax RFK in charge of HHS, and no movement on their personalized cancer drug expected for 1-2 years?

Many_Easy

If he makes a decision next week, that would be 35-41 days. That’s not a few weeks at all. Your vague argument makes no sense. If Tang wanted to be more vague, he would have been more vague. As far as most of it (i.e. critics that hold people at their word accountable) coming from crowd that did nothing last administration - let me remind you that we are in a different administration. By the way, the last administration started the process with an HHS review.

infinite_cura

* **Cannabis rescheduling to Schedule III requires DEA action**, even after Trump calls for it. * **HHS review is already complete** — DEA has the recommendation. * Remaining steps: 1. DEA publishes proposed rule. 2. Public comment period (30–60 days). 3. DEA reviews and issues final rule. 4. Possible legal challenges could delay further. * **Timeline:** * Best case: \~5–6 months. * Normal case: \~9–12 months. * With lawsuits: could stretch longer. Realistically, final rescheduling wouldn’t be effective until **mid-to-late 2027** at the **earliest**.

randomusername0000

HHS moving to regulate/limit cannabis exposure to children. GOP dinosaurs trying to stop S3 (and expected to fail again). Closing loopholes that would circumvent or muddle incoming cannabis regulations. Precursor movements before the S3 finish line. Me likey.

Hipp013

The HHS will probably come out and say daily Happy Meals and Diet Cokes make you live forever

KAI5ER

Oh I think they did. But they played by the rules and were hands off in the decision by the HHS and DEA. The problem is/was the DEA.

Icy_Bookkeeper_208

LEAPS on Big Pharma over the rantings of a worm-brained Highly Regarded HHS Secretary and his equally Regarded cronies is starting to look like a Cornwall Capital play.

TechnicalWhore

You should be fine - too big to fail AND the HHS just blessed AI being used to deny coverage. Winning!

youngbutgood

They said HHS would recommend rescheduling and that one actually played out but they have been wrong on Safe Banking as well.

Ok-Replacement9595

If HHS stands by the recommendation? How herbal medicines fit into MAHAs anti pharma agenda? HHS recommendation for testing within the VA? There are a lot of things that could be asked. Those are just off the top of my head. They asked him about his position relative to anti depressants causing school shootings. They could have asked something.

WollopDollop

Rescheduling is out of HHS's hands at this point, unless Trump/DEA takes an action to go backwards. What were you expecting to be asked?

Ok-Replacement9595

It is my understanding that RFK gave an entire day's testimony, and there was not one question about the HHS recommendation on rescheduling?

IAmOneGuessFromRich

Riiiight. So we’re believing the *science* coming out of the CDC and HHS now that a heroin addict, road kill eating, vaccine denying, worm in the brain piece of shit RFK has fired thousands of the scientists that actually use the scientific method and rather believes in TikTok, internet educated *nutritionists*. I’m sure the remaining scientists and researchers that signed the petition asking the POTUS to fire RFK are also just partisan staffers and not professionals in their trade watching the gutting of their departments and destruction of their research. Anyone defending this fucker might need to go get an MRI, they might also have a worm in the brain. At least I hope so, because otherwise Idiocracy is complete and soon we’ll only be watering plants with Brawndo.

Spankynpetey

RFK, Jr is a moron. A major sibling-controlled study was done in 2024 with 2.4 Million children that showed no causal relationship between Tylenol and autism disproving earlier observational papers that the addled HHS Secretary wants to quote. 😂😂😂 This is living in the era of fake news led by the biggest liar on the planet.

UsernameIWontRegret

You know HHS is mostly professionals who work on these studies for years or even decades? And funny you’re bringing the Democratic Party into this. What do they have to do with big pharmaceutical companies? Unless you’re implying they’re in bed together?

zachmoe

Hopefully the Democratic Party can sue the shit out of the HHS.

UsernameIWontRegret

Sounds like it’s an HHS study being published, not just RFK Jr saying it.

NotHearingYourShit

No, but it can always be worse. And his idiotic bs will make things worse. It’s like saying “there’s too many bicycle related deaths so now we are going to discourage the use of helmets, and defund studies that make bikes safer.” Vaccines and medical research have saved literally billions of lives. RFK jr has personally been responsible for measles outbreaks before he was appointed to head the HHS. He’s an awful human being, and his rise is reflection in how out society is moving backwards with regard to funding medicine and real science. And his supporters are no better.

cod_dawg

Scary day when I’m seeing more educated, informed, and rational viewpoints on WSB than we have running public health policy in HHS